ETF MANAGERS GROUP, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$46,322,000
+13.3%
498,627
-26.9%
0.92%
+19.4%
Q3 2021$40,886,000
-23.9%
682,116
-11.2%
0.77%
-12.2%
Q2 2021$53,707,000
+6.5%
768,018
+5.7%
0.88%
-2.1%
Q1 2021$50,408,000
+173.3%
726,447
+202.6%
0.90%
+121.5%
Q4 2020$18,442,000
-4.4%
240,033
-6.9%
0.40%
-34.0%
Q3 2020$19,283,000
-1.2%
257,829
-16.9%
0.61%
-11.6%
Q2 2020$19,524,000
+53.8%
310,143
+2.6%
0.69%
+17.5%
Q1 2020$12,697,000
-12.6%
302,313
-5.5%
0.59%
+16.6%
Q4 2019$14,530,000
+21.5%
319,900
+22.5%
0.50%
+17.4%
Q3 2019$11,954,000
-49.7%
261,171
-35.5%
0.43%
-43.1%
Q2 2019$23,749,000
+93.1%
405,058
+27.9%
0.76%
+30.6%
Q4 2018$12,300,000
+40.2%
316,684
+56.3%
0.58%
+74.9%
Q3 2018$8,775,000
+19843.2%
202,561
+51.8%
0.33%
+10933.3%
Q2 2018$44,000
-98.9%
133,424
+16.1%
0.00%
-98.8%
Q1 2018$4,056,000
+107.4%
114,890
+112.7%
0.25%
+74.5%
Q4 2017$1,956,00054,0120.14%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders